These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 20597872

  • 21. Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration.
    Slakter JS, Bochow TW, D'Amico DJ, Marks B, Jerdan J, Sullivan EK, Robertson SM, Slakter JS, Sullins G, Zilliox P, Anecortave Acetate Clinical Study Group.
    Ophthalmology; 2006 Jan; 113(1):3-13. PubMed ID: 16368146
    [Abstract] [Full Text] [Related]

  • 22. Visual function following transpupillary thermotherapy with adjusted laser parameters for the treatment of exudative age-related macular degeneration: a pilot study.
    Tranos P, Peter NM, Nath R, Singh MV, Wren S, Dimitrakos S, Rassam S, Kon C.
    Clin Exp Ophthalmol; 2006 Apr; 34(3):226-32. PubMed ID: 16671902
    [Abstract] [Full Text] [Related]

  • 23. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [Abstract] [Full Text] [Related]

  • 24. Limited macular translocation compared with photodynamic therapy in the management of subfoveal choroidal neovascularization in age-related macular degeneration.
    Pawlak D, Glacet-Bernard A, Papp M, Roquet W, Coscas G, Soubrane G.
    Am J Ophthalmol; 2004 May; 137(5):880-7. PubMed ID: 15126153
    [Abstract] [Full Text] [Related]

  • 25. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [Abstract] [Full Text] [Related]

  • 26. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.
    Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, Kotlovker D, Chung CY, Kim RY, FOCUS Study Group.
    Arch Ophthalmol; 2006 Nov; 124(11):1532-42. PubMed ID: 17101999
    [Abstract] [Full Text] [Related]

  • 27. Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.
    Michels S, Wachtlin J, Gamulescu MA, Heimann H, Prünte C, Inhoffen W, Krebs I, Schmidt-Erfurth U.
    Ophthalmology; 2005 Dec; 112(12):2070-5. PubMed ID: 16225928
    [Abstract] [Full Text] [Related]

  • 28. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM, Lai S, Markey CM.
    Clin Exp Ophthalmol; 2007 Dec; 35(1):24-31. PubMed ID: 17300567
    [Abstract] [Full Text] [Related]

  • 29. Time-dependent effects on contrast sensitivity, near and distance acuity: difference in functional parameters? (Prospective, randomized pilot trial of photodynamic therapy versus full macular translocation).
    Ziemssen F, Lüke M, Bartz-Schmidt KU, Gelisken F.
    Graefes Arch Clin Exp Ophthalmol; 2008 May; 246(5):653-9. PubMed ID: 18071731
    [Abstract] [Full Text] [Related]

  • 30. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results.
    Antoszyk AN, Tuomi L, Chung CY, Singh A, FOCUS Study Group.
    Am J Ophthalmol; 2008 May; 145(5):862-74. PubMed ID: 18321465
    [Abstract] [Full Text] [Related]

  • 31. Combination photodynamic therapy and intravitreal ranibizumab in neovascular age-related macular degeneration in a North Indian population: a pilot study.
    Kumar A, Gopalakrishnan K, Sinha S.
    Retina; 2008 Oct; 28(9):1296-301. PubMed ID: 18667951
    [Abstract] [Full Text] [Related]

  • 32. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
    Ergun E, Maár N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M.
    Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
    [Abstract] [Full Text] [Related]

  • 33. Retinal function following transpupillary thermotherapy for occult choroidal neovascularization in age-related macular degeneration: a short-term study by focal electroretinography.
    Pirozzi E, Manganelli C, Piccardi M, Minnella A, Fadda A, Ziccardi L, Coccimiglio F, Falsini B.
    Acta Ophthalmol Scand; 2006 Feb; 84(1):27-35. PubMed ID: 16445436
    [Abstract] [Full Text] [Related]

  • 34. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
    Lazic R, Gabric N.
    Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
    [Abstract] [Full Text] [Related]

  • 35. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
    Kourlas H, Abrams P.
    Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
    [Abstract] [Full Text] [Related]

  • 36. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.
    Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS.
    Br J Ophthalmol; 2006 Mar; 90(3):337-41. PubMed ID: 16488958
    [Abstract] [Full Text] [Related]

  • 37. Transpupillary thermotherapy in subfoveal choroidal neovascular membrane secondary to age-related macular degeneration.
    Verma L, Tewari HK, Nainiwal S, Ravindranathan J.
    Indian J Ophthalmol; 2004 Mar; 52(1):35-40. PubMed ID: 15132377
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.